Other Names:

1-16:0-2-18:1-phosphatidylcholine

16:0-18:1-PC

1-Hexadecanoyl-2-(9Z-octadecenoyl)-sn-glycero-3-phosphocholine

1-Hexadecanoyl-2-(cis-9-octadecenoyl)-sn-glycero-3-phosphocholine

1-palmitoyl-2-oleoyl-GPC

1-Palmitoyl-2-oleoyl-L-alpha-lecithin

1-Palmitoyl-2-oleoyl-lecithin

1-palmitoyl-2-oleoyl-phosphatidylcholine

1-Palmitoyl-2-oleoylphosphatidylcholine

1-Palmitoyl-2-oleoyl-sn-3-phosphocholine

1-Palmitoyl-2-oleoyl-sn-glycero-3-phosphocholine

1-Palmitoyl-2-oleoyl-sn-glycerol-3-phosphocholine

1-Popc

26853-31-6

2-Oleoyl-1-palmitoylphosphatidylcholine

2-Oleoyl-1-palmitoyl-sn-glycero-3-phosphocholine

3-sn-Phosphatidylcholine, 2-oleoyl-1-palmitoyl

4732AH

70778-75-5

97281-44-2

AC1NUZHO

AK387309

AKOS027379127

Brain PC

C42H82NO8P

CHEBI:73001

CMC_12041

CMC_12042

Egg PC

EINECS 248-056-7

GPCho(16:0/18:1omega9)

GPCho(34:1)

HMDB07972

LMGP01010005

LP083162

Palmitoyloleoylphosphatidylcholine

PC(16:0/18:1)

PC(16:0/18:1(9Z))

PC(16:0/18:1omega9)

PC(16:0/18:1w9)

PC(34:1)

phosphatidylcholine (1-16:0-2-18:1)

Phosphatidylcholine(16:0/18:1)

Phosphatidylcholine(16:0/18:1omega9)

Ptd-Cho

(R)-(Z)-(4-Oxido-9-oxo-7-(palmitoylmethyl)-3,5,8-trioxa-4-phosphahexacos-17-enyl)trimethylammonium 4-oxide

SCHEMBL45162

TE895536Y5

UNII-TE895536Y5

WTJKGGKOPKCXLL-VYOBOKEXSA-N

IUPAC name:
[(2R)-3-hexadecanoyloxy-2-[(Z)-octadec-9-enoyl]oxypropyl] 2-(trimethylazaniumyl)ethyl phosphate

PUBCHEM:
5497103

InChIKey:
WTJKGGKOPKCXLL-VYOBOKEXSA-N

InChI:

1S/C42H82NO8P/c1-6-8-10-12-14-16-18-20-21-23-25-27-29-31-33-35-42(45)51-40(39-50-52(46,47)49-37-36-43(3,4)5)38-48-41(44)34-32-30-28-26-24-22-19-17-15-13-11-9-7-2/h20-21,40H,6-19,22-39H2,1-5H3/b21-20-/t40-/m1/s1

Image of the Standard Form:

References in which this Standard Form is mentioned:

Kossatz, Elk and Diez-Alarcia, Rebeca and Gaitonde, Supriya A. and Ramon-Duaso, Carla and Stepniewski, Tomasz Maciej and Aranda-Garcia, David and Muneta-Arrate, Itziar and Tepaz, Elodie and Saen-Oon, Suwipa and Soliva, Robert and Shahraki, Aida and Moreira, David and Brea, Jose and Loza, Maria Isabel and de la Torre, Rafael and Kolb, Peter and Bouvier, Michel and Meana, J. Javier and Robledo, Patricia and Selent, Jana. G protein-specific mechanisms in the serotonin 5-HT2A receptor regulate psychosis-related effects and memory deficits. DOI: 10.1038/s41467-024-48196-2. Available in: http://dx.doi.org/10.1038/s41467-024-48196-2.

Adrian Morales-Pastor1,13, Tamara Miljuš 2,3,4,5,6,13, Miguel Dieguez-Eceolaza 1 , Tomasz Maciej Stępniewski1,7, Vicente Ledesma1 , Franziska M. Heydenreich 8 , Tilman Flock2 , Bianca Plouffe6,9, Christian Le Gouill 6 , Jean Duchaine6 , David A. Sykes 4,10,11, Colin Nicholson4,10, Eline J. Koers4,10, Wolfgang Guba12, Arne C. Rufer 12, Uwe Grether 12, Michel Bouvier 6 , Dmitry B. Veprintsev 2,3,4,10 & Jana Selent 1. Multiple intramolecular triggers converge to preferential G protein coupling in the CB2R. DOI: 10.1038/s41467-025-60003-0.

DOI: alphagpcr.

Specific State ID: 5018	Specific State ID: 5152